Press "Enter" to skip to content

New patent for Nevakar drug EPHEDRINE SULFATE

1
Copyright © DrugPatentWatch. Originally published at New patent for Nevakar drug EPHEDRINE SULFATE

Annual Drug Patent Expirations for EPHEDRINE+SULFATE
Annual Drug Patent Expirations for EPHEDRINE+SULFATE

Ephedrine Sulfate is a drug marketed by Akorn, Amneal, Dr Reddys Labs Ltd, Fresenius Kabi Usa, Nevakar, and Sandoz Inc and, and is included in six NDAs. It is available from five suppliers.

The generic ingredient in EPHEDRINE SULFATE is ephedrine sulfate. Five suppliers are listed for this compound. Additional details are available on the ephedrine sulfate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Nevakar drug EPHEDRINE SULFATE
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions